MilliporeSigma scales up lipid production for COVID-19 vaccines

By The Science Advisory Board staff writers

May 26, 2021 -- MilliporeSigma announced that it has launched a new high-purity synthetic cholesterol product to meet demand for lipids, a component of messenger RNA (mRNA)-based vaccines and therapeutics such as those used for COVID-19.

The launch of this new product follows the company's acquisition of AmpTec, a Hamburg, Germany-based mRNA contract development and manufacturing organization.

The company in February announced the extension of its strategic partnership with BioNTech to accelerate the supply of lipids and increase quantities to be delivered toward the end of 2021. The lipids will be used for the production of the Pfizer-BioNTech COVID-19 vaccine.

Filling of MilliporeSigma
Filling of MilliporeSigma's new synthetic cholesterol product at the company's Darmstadt, Germany facility. Image courtesy of MilliporeSigma.
MilliporeSigma boosts capacity at French assembly facility
MilliporeSigma is adding a single-use assembly production unit to its facility in Molsheim, France.
MilliporeSigma acquires AmpTec
MilliporeSigma has purchased messenger RNA firm AmpTec. The deal is expected to boost MilliporeSigma's ability to develop and manufacture messenger RNA...
MilliporeSigma invests $47M in U.S. biomanufacturing facilities
MilliporeSigma is increasing its manufacturing footprint in the U.S. with a $47 million investment in its Danvers, MA, and Jaffrey, NH, biomanufacturing...
MilliporeSigma holds topping-out ceremony for new membrane plant
MilliporeSigma celebrated the topping out of its new membrane production plant in Darmstadt, Germany, with a ceremony on October 8.
MilliporeSigma expands antibody-drug conjugate manufacturing
MilliporeSigma is expanding its high-potent active pharmaceutical ingredient and antibody-drug conjugate manufacturing capabilities with a $65 million...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter